TLR7 and myelodysplastic syndrome: Consequently, treatments based on TLR7/8 ligands might revert the blockade of myeloid differentiation in MDS patients and increase the number of neutrophils, and therefore have benefits for the patient’s survival and probably improve the efficacy of chemotherapy treatment and patient prognosis.